Showing results (51-60 of 5,557) with videos related to
Sort By:
Pageof 556
Expert Opinion on Pharmacotherapy|January 20, 2016
Epidermal growth factor receptor tyrosine kinase inhibitors in previously treated advanced non-small-cell lung cancer with wild-type EGFRShigeki Mitsuoka, Tomoya Kawaguchi, Akihito Kubo, et al.Expert Opinion on Pharmacotherapy|January 23, 2016
Urinary incontinence in men: current and developing therapy optionsHelena Burden, Paul AbramsExpert Opinion on Pharmacotherapy|January 23, 2016
Developing drugs for use before, during and soon after percutaneous coronary interventionGiuseppe Gargiulo, Aris Moschovitis, Stephan Windecker, et al.Expert Opinion on Pharmacotherapy|January 27, 2016
Nalmefene for the treatment of alcohol use disorders: recent data and clinical potentialMichael SoykaExpert Opinion on Pharmacotherapy|January 23, 2016
Opioid antagonists in broadly defined behavioral addictions: a narrative reviewMarcelo Piquet-Pessôa, Leonardo F FontenelleExpert Opinion on Pharmacotherapy|May 17, 2016
The efficacy and safety of teneligliptin added to ongoing metformin monotherapy in patients with type 2 diabetes: a randomized study with open label extensionAndrew Bryson, Paul E Jennings, Laszlo Deak, et al.Expert Opinion on Pharmacotherapy|May 28, 2016
How has treatment changed for blast phase chronic myeloid leukemia patients in the tyrosine kinase inhibitor era? A review of efficacy and safetySalvatore Perrone, Fulvio Massaro, Giuliana Alimena, et al.Expert Opinion on Pharmacotherapy|March 3, 2016
Stiripentol and vigabatrin current roles in the treatment of epilepsyCatherine ChironExpert Opinion on Pharmacotherapy|April 8, 2016
Treatment patterns and factors associated with the use of everolimus among post-menopausal women with HR+/HER2- metastatic breast cancer: a retrospective US claims studyAnnie Guérin, Yanni Hao, Derek Tang, et al.Expert Opinion on Pharmacotherapy|July 22, 2015
Pharmacological basis and scientific rationale underlying the targeted use of inhaled corticosteroid/long-acting β2-adrenergic agonist combinations in chronic obstructive pulmonary disease treatmentGirolamo Pelaia, Carmelo Caio Muzzio, Alessandro Vatrella, et al.Pageof 556